Dominic Smethurst

Dominic Smethurst

Chief Medical OfficeratCorbus Pharmaceuticals Holdings· In proxies 2023–2025

Pay in FY2025-38% from the year before · Corbus Pharmaceuticals Holdings stock -31.0% the same year

Dominic Smethurst was paid $1.8M in FY2025 (Dec), down 38%. Corbus Pharmaceuticals Holdings stock fell 31.0% that year.

Pay$100 in the stock at the end of FY22 → $246
Pay is from the Summary Compensation Table of each Corbus Pharmaceuticals Holdings proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Corbus Pharmaceuticals HoldingsPublic company · 3 yr
    • Chief Medical Officer2023 – Present · 3 yrStock in role +29%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?